SmallCaps Podcast

Vox Royalty Corp (TSX-V: VOX) chairman and CEO Kyle Floyd joins Small Caps to discuss the company’s record quarterly revenue for the three months ending September (Q3 FY2021). Vox remains on track to meet the upper end of its 2021 revenue guidance of C$4-5 million (A$4.37-5.46 million). The company’s revenue for Q3 FY2021 exceeded C$1.22 million on the back of gold production from Karora Resources’ (TSX: KRR) Hidden Secret deposit within the Higginsville operation in Western Australia, which was covered by the Dry Creek royalty. High production from Mineral Resources’ (ASX: MIN) Koolyanobbing operation in WA also underpinned the record revenue.Article:https://smallcaps.com.au/vox-royalty-corporation-record-september-quarter-upper-end-revenue-guidance/

See omnystudio.com/listener for privacy information.

Altech Chemicals (ASX: ATC) managing director Iggy Tan joins Small Caps to discuss the significant breakthrough the company has made in its research and development of lithium-ion battery technology. Altech has treated silicon particles with its innovative coating technology to successfully produce and test a series of battery anode materials that have about 30% higher retention capacity compared to conventional anode materials. The tests also addressed previous challenges in using silicon for lithium-ion battery anodes, including particle swelling, first cycle capacity losses of up to 50% and rapid battery degradation, and announced “significant” improvement. A phase two research and development program is planned to improve on the 30% energy capacity retention and develop a pilot plant.For more information:https://smallcaps.com.au/stocks/ATC/

See omnystudio.com/listener for privacy information.

TNG Limited (ASX: TNG) managing director Paul Burton joins Small Caps to discuss the company’s recent decision to relocate the proposed TIVAN downstream processing facility to its Mount Peake mine site about 235km northwest of Alice Springs following a thorough review. Clough recently completed the design for the Mount Peake integrated mining and processing operation, with an updated capital cost estimate due in May. TNG recently raised $12.5 million and will produce vanadium, titanium dioxide and iron products from the Mount Peake operation.Articles:https://smallcaps.com.au/clough-completes-design-tng-mount-peake-mining-tivan-processing-operation/https://smallcaps.com.au/tng-appoints-clough-work-on-mount-peak-mine-site-layout/For more information:https://smallcaps.com.au/stocks/TNG/

See omnystudio.com/listener for privacy information.

Amplia Therapeutics (ASX: ATX) chief scientific officer Mark Devlin joins Small Caps to discuss the latest achievements made in the company’s research and development of its anti-cancer drug AMP945. The pharmaceutical company revealed new data from its recent phase one clinical trial that shows the ability of AMP945 to inhibit focal adhesion kinase (FAK) in healthy human volunteers when administered as an oral capsule. FAK activity was measured in skin samples taken before and after doses of the drug and showed a reduction in activity can be achieved at safe and well-tolerated dosage levels. The data will be used to further refine the doses of AMP945 to be used in an upcoming phase two clinical trial in patients with pancreatic cancer. It will also provide guidance for the phase two trial in pulmonary fibrosis planned for the second half of 2022.Articles:https://smallcaps.com.au/amplia-therapeutics-anti-cancer-drug-amp945-inhibit-focal-adhesion-kinase/https://smallcaps.com.au/amplia-therapeutics-secures-renowned-oncology-drug-development-expert-clinical-advisor/For more information:https://smallcaps.com.au/stocks/ATX/

See omnystudio.com/listener for privacy information.

Kin Mining (ASX: KIN) managing director Andrew Munckton joins Small Caps to discuss the company’s exploration program at its 100% owned Cardinia gold project in Western Australia. The company recently revealed a new shallow gold discovery made during initial aircore drilling of the Pegasus prospect, located adjacent to the 374,000oz Bruno-Lewis deposit. Drilling highlights included 4m at 10.1g/t gold from 24m and 8m at 3.08g/t from 8m. Assays are anticipated from more than 100 holes testing the northwest extension of Pegasus below the extensive gold-in-soil anomaly. The next phase of work, comprising reverse circulation and diamond drilling to confirm mineralisation in fresh rock, is planned to begin as soon as drill rigs become available.Article:https://smallcaps.com.au/kin-mining-hits-gold-mineralisation-pegasus-target-cardinia-project/For more information:https://smallcaps.com.au/stocks/KIN/

See omnystudio.com/listener for privacy information.

NickelX (ASX: NKL) managing director Matthew Gauci joins Small Caps to discuss the company’s plans to acquire the Cosmos South nickel project in Western Australia. Described as “highly prospective but poorly explored”, the property is located on the Wiluna Greenstone Belt just 10km south of Western Area’s (ASX: WSA) large Cosmos nickel mine and 20km north of BHP’s (ASX: BHP) Leinster nickel operation. NickelX has signed a binding term sheet for an option over 100% of the ground, which will see the base metals explorer commit $500,000 in exploration spending over 24 months and issue the private vendor about $300,000 worth of shares in two tranches. The property ranked highly on NickelX’s acquisition target list and is believed to represent a “very compelling” nickel target.Article:https://smallcaps.com.au/nickelx-clinches-deal-acquire-key-wa-nickel-property/For more information:https://smallcaps.com.au/stocks/NKL/

See omnystudio.com/listener for privacy information.

Kingston Resources (ASX: KSN) managing director Andrew Corbett joins Small Cap to discuss the company’s acquisition of the Mineral Hill gold mine in NSW. The $22.7 million purchase from US-based Quintana MH Holding will transform Kingston from gold explorer to producer, with 40,000 ounces of gold expected to be produced from tailings over 29 months. The company also aims to re-establish gold production from the mine in late 2023. In addition to gold, the project is believed to offer exposure to copper, zinc, lead and silver.Article:https://smallcaps.com.au/kingston-resources-upgrades-gold-producer-status-mineral-hill-mine-acquisition/For more information:https://smallcaps.com.au/stocks/KSN/

See omnystudio.com/listener for privacy information.

Argenica Therapeutics (ASX: AGN) chief executive officer Dr Liz Dallimore joins Small Caps to discuss the development pathway of the company’s lead drug candidate ARG-007. The biotech has developed unique neuroprotective technology to reduce brain cell death following stroke and other brain injuries and has begun the preliminary work required for an upcoming phase one clinical trial. Argenica describes ARG-007 as a simple, non-disruptive intravenous injection that works to protect the brain against the damaging effects of stroke, extend the treatment window for stroke patients, reduce special care requirements and intensive rehabilitation time, and reduce hospitalisation time and post-care costs. The recently listed company raised $7 million in its initial public offering with funds primarily going towards pre-clinical and product development activities, safety assessments, regulatory approval preparation and intellectual property protection.Articles:https://smallcaps.com.au/argenica-therapeutics-positive-pre-clinical-results-stroke-drug-arg-007-hie/https://smallcaps.com.au/argenica-therapeutics-start-phase-1-clinical-trials-early-next-year/More company information:https://smallcaps.com.au/stocks/AGN/

See omnystudio.com/listener for privacy information.

E79 Gold Mines (ASX: E79) chief executive office Ned Summerhayes joins Small Caps to discuss the company’s exploration plans across its two flagship gold projects in Western Australia. E79 recently listed on the ASX after raising $7 million to advance its Laverton South and Jungar Flats projects. A drilling program is now underway at Laverton South, which is located in the world-class Laverton gold district.More company information:https://smallcaps.com.au/stocks/E79/

See omnystudio.com/listener for privacy information.

Spectur (ASX: SP3) managing director Gerard Dyson joins Small Caps to discuss the company’s vision of harnessing natural resources to develop autonomous sensing, thinking and action technology that’s available anywhere and at anytime. Powered by solar, Spectur’s disruptive technology provides security, surveillance and warning solutions for various sectors including government, utilities, institutional and building and construction. The company recently secured a contract to provide security solutions for Australian telecommunications leader Optus.Articles:https://smallcaps.com.au/spectur-signs-contract-optus-protect-remote-assets/https://smallcaps.com.au/spectur-reports-best-first-quarter-performance-on-record/https://smallcaps.com.au/spectur-targets-wa-market-dominance-security-technology/More company information:https://smallcaps.com.au/stocks/SP3/

See omnystudio.com/listener for privacy information.